4117 fundamentals
An in-depth look to GENERAL BIOLOGICAL CORP operating, investing, and financing activities
4117 free cash flow for H2 24 is -378.47 M TWD. For 2024, 4117 free cash flow was -1.66 B TWD and operating cash flow was -115.06 M TWD.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: TWD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM